-
Company News
Uni-Bio Science Group Joins Forces with Wenzhou Medical University National Engineering Research Center and Ouhai District Government to Build Growth Factor Innovation Ecosystem and Accelerate Regenerative Medicine Strategy Layout30 December,2025
Learn More -
Company News
Uni-Bio Science Group Honored with SCMP "Company of the Year" Award16 December,2025
Learn More -
Company News
Uni-Bio Science Group Embarks on New Strategy and Launches New Website, Advancing Towards Becoming a Global Leader in Regenerative Medicine24 November,2025
Learn More -
Company News
Uni-Bio Science Group and Kexing Biopharm Forge Strategic Partnership to Accelerate Global Expansion of Osteoporosis Treatment Bogutai®12 September,2025
Learn More
-
Uni-Bio Science's Chairman Won HK Innopreneur Awards – GBA+ AwardCompany News
17 February,2023
-
2022 Interim Results Pinup® and Boshutai® Generated Remarkable Turnover while Achieving Record High Profit Aim to Build a Highly Commercial-Driven and Specialized R&D PlatformCompany News
29 August,2022
-
Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)Company News
28 June,2022
-
Uni-Bio Science Group opens Hong Kong research centre,Future R&D focus in four major businessesCompany News
13 June,2022
-
Uni-Bio Science Group’s BOSHUTAI® (Acarbose Tablets) successfully selected for Henan thirteen provinces alliance procurementCompany News
02 June,2022